|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02367 GIANT BIOGENE
Nominal 
28.580 -1.200 (-4.030%) Ranking Overview
Ranking based on 14 research report(s)
Average Ranking 2.14
|
Strong Buy (1)
0
|
Buy (2)
12
|
Hold (3)
2
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 183.00 RMB (cts) | |
| Net Profit | 1,914.84 RMB (MIL) | DPS | 121.04 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 2,004.90 | 194.50 | 108.89 | -- | 3,203.00 | 1,749.00 |
| 2027 | 2,203.00 | 213.00 | 122.40 | -- | 3,812.00 | 2,045.00 |
| 2028 | 2,266.85 | 212.55 | 131.15 | -- | 2,432.00 | 2,180.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 3,203.00 | 311.00 | 130.79 | HUATAI FIN HLDGS HK | Buy | 85.00 | 24/10/2025 | |
| 2026 | 2,293.60 | 230.00 | 70.00 | MACQUARIE | OutPerform | 61.00 | 03/12/2025 | |
| 2026 | 2,250.00 | 210.00 | 105.00 | BANK OF AMERICA | Buy | 55.50 | 02/12/2025 | |
| 2026 | 1,917.00 | 179.00 | 107.00 | CICC | Outperform | 49.00 | 20/03/2026 | |
| 2026 | 2,083.00 | 199.00 | 63.00 | HSBC | Buy | 46.40 | 05/12/2025 | |
| 2026 | 1,901.20 | 178.00 | 53.00 | GOLDMAN SACHS | Buy | 46.00 | 20/03/2026 | |
| 2026 | 2,977.00 | 278.00 | 156.00 | CSC | Buy | 45.00 | 02/12/2025 | |
| 2026 | 2,164.00 | 202.00 | -- | CITIC SEC | Buy | 44.00 | 19/01/2026 | |
| 2026 | 1,749.00 | 169.00 | -- | MORGAN STANLEY | Overweight | 42.00 | 12/02/2026 | |
| 2026 | 1,964.00 | 183.00 | 110.78 | CMB INT'L SEC | Buy | 38.70 | 23/03/2026 | |
| 2026 | 1,958.00 | 180.70 | 120.50 | CITIGROUP | Buy | 37.00 | 19/03/2026 | |
| 2026 | 2,002.80 | 190.00 | 120.00 | HAITONG | OutPerform | 36.20 | 22/03/2026 | |
| 2026 | 2,007.00 | 200.00 | 123.00 | CHINA MERCHANTS | Hold | 35.00 | 22/12/2025 | |
| 2026 | 1,911.00 | 178.00 | 52.29 | UBS | Neutral | 34.00 | 24/03/2026 | |
| 2027 | 3,812.00 | 371.00 | 133.42 | HUATAI FIN HLDGS HK | -- | -- | 24/10/2025 | |
| 2027 | 2,867.10 | 290.00 | 90.00 | MACQUARIE | -- | -- | 03/12/2025 | |
| 2027 | 2,668.00 | 249.00 | 125.00 | BANK OF AMERICA | -- | -- | 02/12/2025 | |
| 2027 | 2,147.00 | 201.00 | 120.00 | CICC | -- | -- | 20/03/2026 | |
| 2027 | 2,313.00 | 220.00 | 70.00 | HSBC | -- | -- | 05/12/2025 | |
| 2027 | 2,195.50 | 205.00 | 61.00 | GOLDMAN SACHS | -- | -- | 20/03/2026 | |
| 2027 | 3,639.00 | 340.00 | 190.00 | CSC | -- | -- | 02/12/2025 | |
| 2027 | 2,532.00 | 236.00 | -- | CITIC SEC | -- | -- | 19/01/2026 | |
| 2027 | 2,104.00 | 203.00 | -- | MORGAN STANLEY | -- | -- | 12/02/2026 | |
| 2027 | 2,201.00 | 206.00 | 124.29 | CMB INT'L SEC | -- | -- | 23/03/2026 | |
| 2027 | 2,055.00 | 189.70 | 120.50 | CITIGROUP | -- | -- | 19/03/2026 | |
| 2027 | 2,148.30 | 200.00 | 130.00 | HAITONG | -- | -- | 22/03/2026 | |
| 2027 | 2,205.00 | 220.00 | 135.00 | CHINA MERCHANTS | -- | -- | 22/12/2025 | |
| 2027 | 2,045.00 | 191.00 | 54.90 | UBS | -- | -- | 24/03/2026 | |
| 2028 | 2,432.00 | 227.00 | 137.80 | CMB INT'L SEC | -- | -- | 23/03/2026 | |
| 2028 | 2,222.00 | 205.10 | 124.50 | CITIGROUP | -- | -- | 19/03/2026 | |
| 2028 | 2,311.70 | 220.00 | 140.00 | HAITONG | -- | -- | 22/03/2026 | |
| 2028 | 2,180.00 | 204.00 | 60.13 | UBS | -- | -- | 24/03/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 26/03/2026 16:17 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,914,836 |
| %Change | -7.153% |
| EPS / (LPS) | RMB 1.830 |
| NBV Per Share (¥) | RMB 9.255 |